Status:
UNKNOWN
Tableted COVID-19 Therapeutic Vaccine
Lead Sponsor:
Immunitor LLC
Collaborating Sponsors:
Immunitor Inc.
Conditions:
Covid19
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Safety and immunogenicity one-month study in healthy individuals administered once-daily pill of therapeutic vaccine made from heat-inactivated plasma from donors with COVID-19. Healthy, at least 20, ...
Detailed Description
Experimental batch of tableted thermostable vaccine obtained from pooled plasma of COVID-19 patients is produced. The goal of this trial is test safety and immunogenicity of once-per-day day administe...
Eligibility Criteria
Inclusion
- Confirmed cases of Covid-19 (all by RT-PCR from same laboratory)
- Mild to severe clinical presentation (identified at the time of admission to ward by National Early Warning Score NEWS-2; mild 0-4; severe 5-6)
Exclusion
- Unable to take oral medication,
- Immunocompromised
- Known comorbid condition like hypertension, cardiovascular disease, diabetes mellites, asthma, COPD, cerebrovascular disorder, malignancy of any type, pregnancy,
- BMI less than 18
- Smoking history (more than one pack per day)
Key Trial Info
Start Date :
May 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04380532
Start Date
May 15 2020
End Date
June 15 2021
Last Update
May 27 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Immunitor Inc
Vancouver, BC - British Columbia, Canada, V6K 2G8
2
Aldar Bourinbayar
Ulaanbaatar, BZD, 3-khoroo, Mongolia, 13381